B2IS11 AF NFT

6,7-dimethyl-8-ribityllumazine synthase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiepmb22hf6bw5pnjuk7kjpket35lkwxeceo2fewloo243rovj5i5q/metadata.json
IPFS of structure file: 
bafybeibfjciobxloffnrdeyq7cyqsh6lb3gwq4fjbp6zdl76vcijcrvmte/AF-B2IS11-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x71112d4fF7ebb3b617963c05f052289e073082FD
First NFT owner address (bech32): 
genesis1wygj6nlhawemv9uk8szlq53gncrnpqha56an79
Current NFT ID #346796 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
346796
Accession (UniProt):
B2IS11
Name::
6,7-dimethyl-8-ribityllumazine synthase
Experimental Method:
Predicted structure
Sequence source:
Streptococcus pneumoniae (strain CGSP14)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2IS11 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2IS11|RISB_STRPS 6,7-dimethyl-8-ribityllumazine synthase OS=Streptococcus pneumoniae (strain CGSP14) OX=516950 GN=ribH PE=3 SV=1 MNTYEGNLVANNIKIGIVVARFNEFITSKLLSGALDNLKRENVNEKDIEVAWVPGAFEIPLIASKMAKSKKYDAIICLGAVIRGNTSHYDYVCSEVSKGIAQISLNSEIPVMFGVLTTDTIEQAIERAGTKAGNKGSECAQGAIEMVNLIRTLDA